Brought to you by 
Applied Biosystems licenses U. of Washington's ICAT
12 Dec 2000
Executive Summary
In an effort to expand its proteomics portfolio, Applera Corp.'s (formerly PE Corp.) subsidiary Applied Biosystems licensed exclusive worldwide rights to develop and market ICAT (isotope coded affinity tag) reagents from the University of Washington.
Deal Industry
- In Vitro Diagnostics
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Applied Biosystems licenses U. of Washington's ICAT
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice